ALDER BIOPHARMACEUTICALS INC Uncategorized Contracts & Agreements
24 Contracts & Agreements
- Letter Agreement, dated October 21, 2019, between Robert W. Azelby and Alder BioPharmaceuticals, Inc (Filed With SEC on October 22, 2019)
- 2018 Inducement Award Plan, as Amended and Restated (Filed With SEC on August 6, 2019)
- Quality Agreement on Manufacturing and Testing of Bulk Drug Substance between Alder BioPharmaceuticals, Inc. and Sandoz GmbH, effective July 27, 2018 (Filed With SEC on February 25, 2019)
- Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH, effective May 4, 2015 (Filed With SEC on February 25, 2019)
- Amendment No. 5 to the Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH, effective January 1, 2019 (Filed With SEC on February 25, 2019)
- Amendment No: 4 to the Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH, effective June 15, 2018 (Filed With SEC on February 25, 2019)
- Amendment No: 3.1 to the Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH, effective December 22, 2017 (Filed With SEC on February 25, 2019)
- Amendment No: 2 to the Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH, effective November 17, 2016 (Filed With SEC on February 25, 2019)
- Amendment No: 1 to the Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH, effective September 19, 2016 (Filed With SEC on February 25, 2019)
- Offer Letter between Alder BioPharmaceuticals, Inc. and Carlos E. Campoy dated December 4, 2018 (Filed With SEC on February 25, 2019)
- 2018 Inducement Award Plan (Filed With SEC on August 7, 2018)
- Offer Letter between the Company and Robert W. Azelby dated June 4, 2018 (Filed With SEC on August 7, 2018)
- Offer Letter between the Company and Erin Lavelle dated March 17, 2018 (Filed With SEC on May 8, 2018)
- Offer Letter between the Company and Paul B. Cleveland dated March 18, 2018 (Filed With SEC on May 8, 2018)
- Amendment to Offer Letter between Alder BioPharmaceuticals, Inc., and Elisabeth A. Sandoval, dated January 2, 2018 (Filed With SEC on February 26, 2018)
- Additional abbreviations mayalso be used though not in the above list. (Filed With SEC on December 22, 2014)
- EXHIBIT B LICENSEAGREEMENT (Filed With SEC on May 1, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on April 25, 2014)
- Alder BioPharmaceuticals July 19, 2005 (Filed With SEC on March 19, 2014)
- Alder BioPharmaceuticals July 19, 2005 (Filed With SEC on March 19, 2014)
- Alder BioPharmaceuticals July 19, 2005 (Filed With SEC on March 19, 2014)
- Alder BioPharmaceuticals July 19, 2005 (Filed With SEC on March 19, 2014)
- EARLY ENTRY AGREEMENT (Filed With SEC on March 19, 2014)
- EXHIBIT B LICENSEAGREEMENT (Filed With SEC on March 19, 2014)
